ZENSUN (SHANGHAI) SCIENCE & TECH CO LTD has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ZENSUN SHANGHAI SCIENCE & TECHNOLOGY LTD, OSI EYETECH INC and AFFIRIS FORSCHUNGS UND ENTWICKLUNGS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | United States | 8 | |
#3 | Republic of Korea | 3 | |
#4 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Environmental technology | |
#6 | Computer technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Climate change adaptation technologies | |
#6 | Microorganisms | |
#7 | Syringes | |
#8 | Measuring microorganism processes | |
#9 | Healthcare informatics | |
#10 | Dentistry |
# | Name | Total Patents |
---|---|---|
#1 | Zhou Mingdong | 21 |
Publication | Filing date | Title |
---|---|---|
KR20170089438A | Injection pump control method, control unit, and injection pump | |
EP2918283A1 | Extended release of neuregulin for improved cardiac function |